User had minor hair transplant in 2020, used Fin since 2008, Min since 2014, and added microneedling in 2022. Routine was irregular with no severe effects.
The user began using topical minoxidil in 2020 without regrowth, then added 0.5mg finasteride, 2.5mg oral minoxidil daily, topical minoxidil/finasteride most days, and weekly micro needling since December 2022. They also use peppermint-infused jojoba oil for hair health and have noticed less gray hair.
The post discusses the potential of GT20029 in treating hair loss, questioning if it will replace finasteride or be used alongside existing treatments. A reply indicates that its role is still uncertain.
User started oral minoxidil 2.5mg in September 2022, experienced initial shedding, then reduced shedding, but now shedding increased again after 8 months. User is a 43-year-old female also on Spironolactone, seeking advice.
User started 0.5 mg dutasteride in September 2022 and oral minoxidil in February 2023. Hair loss increased initially, but improved after increasing minoxidil dosage.
Latanoprost for hair loss is available in Canada at Ford's Family Pharmacy in New Brunswick, with up to 0.03% concentration, six times stronger than glaucoma medication Xalatan.
Low-Butterscotch-608's progress in treating their hair loss with finasteride and minoxidil over the course of two years, as well as opinions on whether they should consider a hair transplant to address further receding. Replies included advice about adding microneedling to the protocol.
The conversation is about the difficulty in obtaining GT20029, a hair loss treatment, due to patent issues and the need to resort to group buys or Chinese labs for acquisition. Specific treatments mentioned include Minoxidil, finasteride, and RU58841.